Prometheus Panta: The new gold standard for biologics characterization

Explore how Multiplexing Optical Methods (MOM™) and Prometheus Panta C help drive Quality by Design (QbD) through process control, comparability studies, and lifecycle management in biologics.

A data-driven approach to Quality by Design (QbD): Learn how to identify CQAs and define design space in biologics development using Multiplexing Optical Methods (MOM™) and Prometheus Panta.

This guide provides an overview of the key analytical parameters obtained with Prometheus Panta, their definitions and practical relevance for protein characterization and drug development.

When working with membrane proteins, whether you’re troubleshooting aggregation, testing new solubilization strategies, or deciding when to switch detergents read this guide for practical solutions.

Learn about Prometheus Panta C: A next-generation stability characterization platform that's helping biomanufacturers bring automation into the analytical core of their development and process control

Dr. Marius Müller of Johnson & Johnson Innovative Medicine shares insights from questions about the use of nanoDSF™ technology for ID-testing and at several late stages of biotherapeutics development.

NanoTemper Technologies announces the launch of Prometheus Panta C, a solution designed to meet the evolving needs of biopharmaceutical development—from preclinical phase to commercial manufacturing.

Learn how to enhance your lab's efficiency with Prometheus Panta, from using capillary chips for high-throughput sample loading to solutions for seamless integration in automated workflows

Expert Marius Müller, PhD, Team Lead at Johnson & Johnson Innovative Medicine, shares insights into three significant trends that have potential to reshape the biopharma and biomanufacturing industry

Use this curated list of must-attend 2025 biologics conferences to plan your year. Find out when and where each conference takes place, who will be there, and what you can expect.